行情

ALPN

ALPN

Alpine Immune
NASDAQ

实时行情|Nasdaq Last Sale

2.775
-0.105
-3.65%
交易中 12:09 04/02 EDT
开盘
2.900
昨收
2.880
最高
2.925
最低
2.760
成交量
3,406
成交额
--
52周最高
8.24
52周最低
2.050
市值
5,158.14万
市盈率(TTM)
-1.2136
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ALPN价格均价为11.75,最高价位17.00,最低价为8.00。

EPS

ALPN 新闻

更多
  • 午盘:美股维持涨势 原油大幅拉升
  • 新浪美股 · 14分钟前
  • 瑞幸与资本战争 媒体下的洪流猛兽
  • 新浪财经-自媒体综合 · 17分钟前
  • 佩洛西希望鲍威尔从“大局考虑” 请美联储帮助各州
  • 新浪美股 · 23分钟前
  • 一切都是COO的错
  • 新浪财经-自媒体综合 · 24分钟前

所属板块

生物技术和医学研究
+2.28%
制药与医学研究
+1.71%

热门股票

代码
价格
涨跌幅

ALPN 简况

Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a process known as directed evolution. The vlgD platform exploits both known and unknown interactions at immune synapse through a process called direct evolution for patients living with cancer, autominnue/inflammatory conditions and chronic infectious disease. It optimizes native immune system proteins for use as therapeutics. The Company also developed Transmembrane Immunomodulatory Protien (TIP) technology, based on the vIgD platform, to enhance engineered cellular therapies. TIP program is created to help companies focused on engineered cellular therapies.
展开

微牛提供Alpine Immune Sciences Inc(NASDAQ-ALPN)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ALPN股票新闻,以帮助您做出投资决策。